We are live on ! Find out more
ACP

Altitude Crest Partners Portfolio holdings

AUM $234M
This Fund
S&P 500
This Quarter Est. Return
+12.17%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$149M
AUM Growth
–
Cap. Flow
+$139M
Cap. Flow %
92.85%
Top 10 Hldgs %
99.58%
Holding
12
New
12
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
LEGN icon
Legend Biotech
LEGN
+$34.3M
2
DHR icon
Danaher
DHR
+$25.9M
3
BBIO icon
BridgeBio Pharma
BBIO
+$22.7M
4
ARGX icon
argenx
ARGX
+$13.7M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$10.1M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LEGN icon
1
Legend Biotech
LEGN
$4.55B
$32.6M 21.82%
+541,816
New +$34.3M
BBIO icon
2
BridgeBio Pharma
BBIO
$16.2B
$30.5M 20.38%
+754,560
New +$22.7M
DHR icon
3
Danaher
DHR
$127B
$28.1M 18.82%
+121,600
New +$25.9M
ARGX icon
4
argenx
ARGX
$53.3B
$11.2M 7.51%
+29,500
New +$13.7M
BMRN icon
5
BioMarin Pharmaceuticals
BMRN
$11.3B
$11M 7.36%
+114,042
New +$10.1M
APLS
6
DELISTED
Apellis Pharmaceuticals
APLS
$9.11M 6.1%
+152,200
New +$7.72M
ROIV icon
7
Roivant Sciences
ROIV
$25.1B
$9.07M 6.07%
+808,061
New +$7.88M
KNSA icon
8
Kiniksa Pharmaceuticals
KNSA
$4.8B
$8M 5.35%
+456,041
New +$7.5M
EXAS
9
DELISTED
Exact Sciences
EXAS
$7.33M 4.91%
+99,130
New +$6.5M
ALGS icon
10
Aligos Therapeutics
ALGS
$31.9M
$1.89M 1.26%
+113,787
New +$1.96M
AMAM
11
DELISTED
Ambrx Biopharma Inc
AMAM
$614K 0.41%
+43,100
New +$490K
SRZNW icon
12
Surrozen Inc Warrant
SRZNW
$7.69K 0.01%
+384,573
New +$7.84K

Similar funds

APWM
Atlas Private Wealth Management Albany, New York $238M AUM 17.48% 1-Year Est. Return
SWM
Soundmark Wealth Management Kirkland, Washington $225M AUM 17.51% 1-Year Est. Return
CC
Cipher Capital New York $216M AUM 23.63% 1-Year Est. Return
HI
Handelsinvest Investeringsforvaltning Herning, Denmark $208M AUM 35.27% 1-Year Est. Return
CC
Codex Capital New York $205M AUM 65.13% 1-Year Est. Return
DAM
Derbend Asset Management Peachtree City, Georgia $203M AUM 22.97% 1-Year Est. Return
BG
Benedetti & Gucer Atlanta, Georgia $201M AUM 25.95% 1-Year Est. Return
VLC
Van Leeuwen & Company Princeton, New Jersey $197M AUM 44.16% 1-Year Est. Return

Altitude Crest Partners's Q4 2023 Portfolio in Review

Q4 2023 is the first quarter with a 13F filing on record for Altitude Crest Partners, which disclosed 12 positions worth $149M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Legend Biotech: 541,816 shares worth $32.6M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Altitude Crest Partners's largest Q4 2023 buy was Legend Biotech: 541,816 shares worth $32.6M.
  • Altitude Crest Partners's ten largest holdings make up 100% of its $149M portfolio in Q4 2023.
  • Altitude Crest Partners disclosed 12 positions in Q4 2023, its first 13F filing on record.

Based on Altitude Crest Partners's 13F filing for Q4 2023, filed 14 Feb 2024.